Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease : A Case Control Study

Several studies showed high serum copper levels in Alzheimer's disease (AD). The present study applied a newly developed method to detect serum copper free from proteins (free-Cu). Forty-four patients affected by dementia due to AD, thirty-six patients affected by mild cognitive impairment (MCI) due to AD, and twenty-eight healthy controls underwent clinical, cognitive, and MRI assessment. The new method showed higher free-Cu concentrations in MCI and dementia due to AD compared to controls (p < 0.0001). No correlation between copper levels, cognitive or MRI measures were found.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:61

Enthalten in:

Journal of Alzheimer's disease : JAD - 61(2018), 3 vom: 15., Seite 907-912

Sprache:

Englisch

Beteiligte Personen:

Rozzini, Luca [VerfasserIn]
Lanfranchi, Francesco [VerfasserIn]
Pilotto, Andrea [VerfasserIn]
Catalani, Simona [VerfasserIn]
Gilberti, Maria Enrica [VerfasserIn]
Paganelli, Matteo [VerfasserIn]
Apostoli, Pietro [VerfasserIn]
Padovani, Alessandro [VerfasserIn]

Links:

Volltext

Themen:

789U1901C5
Alzheimer’s disease
Amyloid beta-protein
Copper
Dementia
Journal Article
Medial temporal lobe atrophy
Mild cognitive impairment

Anmerkungen:

Date Completed 17.01.2019

Date Revised 17.01.2019

published: Print

Citation Status MEDLINE

doi:

10.3233/JAD-170552

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM27994330X